Agalsidase alfa

阿加糖酶α

Report date: 2024/04/28 10:08:57

Base Information

Drug NameAgalsidase alfa
Drug Alias Name半乳糖苷酶α （Shire）Agalsidase α (Shire)Agalsidase alfa (Shire)Agalsidase alpha (Shire)Agalsidasum alfa (Shire) +[14] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsFabry Disease
Approved Indications in ChinaFabry Disease
Original Approved Country/TerritoryEU
Original Approved Date2001/08/03
Country/TerritoryCzechiaCanadaUnited States +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShire Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo DainipponVetter Pharma-Fertigung Gmbh & Co KgTakeda Pharmaceuticals International Ag
Inactive CompaniesShireDhl Supply Chain (Netherlands) BvBaylor Research Institute Llc +[7] 
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeA16AB03
Related LinksWikipediaDrugBankKEGG